Safety and Tolerability of Increased Rate of Infusion of Intravenous Immunoglobulin G, 10% in Antibody-Deficient Patients

By Gelfand Erwin   Hanna Kim  

Journal of Clinical Immunology, Vol. 26, Iss. 3, 2006-05 ,pp. : 284-290

Springer Publishing Company

Access to resources Recommend Favorite

Efficacy and safety of Privigen^®, a novel liquid intravenous immunoglobulin formulation, in adolescent and adult patients with chronic immune thrombocytopenic purpura

By Robak T.   Salama A.   Kovaleva L.   Vyhovska Y.   Davies S. V.   Mazzucconi M. G.   Zenker O.   Kiessling P.    

Hematology, Vol. 14, Iss. 4, 2009-08 ,pp. : 227-236

Maney Publishing

Access to resources Recommend Favorite

Efficacy and safety of a new intravenous immunoglobulin 10% formulation (octagam^® 10%) in patients with immune thrombocytopenia

By Robak Tadeusz   Mainau Claudia   Pyringer Barbara   Chojnowski Krzysztof   Warzocha Krzysztof   Dmoszynska Anna   Straub Jan   Imbach Paul  

Hematology, Vol. 15, Iss. 5, 2010-10 ,pp. : 351-359

Maney Publishing

Access to resources Recommend Favorite

Efficacy and Tolerability of an Argentine Intravenous Immunoglobulin in Pediatric Patients with Primary Immunodeficiency Diseases

By Krasovec S.   Ornani A.   Oleastro M.   Rosenzweig S.   Roy A.   Perez L.   Campos G.   MarÍn N.   Martinez A.   Mahieu C.   Manfredi M.   Sisti A.   Zelazko M.  

Journal of Clinical Immunology, Vol. 27, Iss. 2, 2007-03 ,pp. : 227-232

Springer Publishing Company

Access to resources Recommend Favorite

Use of Intravenous Immunoglobulin (IVIG) Therapy in Adults

By Herrod Henry G.  

Allergy and Asthma Proceedings, Vol. 15, Iss. 6, 1994-11 ,pp. : 309-312

OceanSide Publications, Inc

Access to resources Recommend Favorite